- Generic name
- Levetiracetam
- Strength
- 1500 mg
- Dosage form
- Xr Tablet
- Manufactured by
- Renata PLC.
Epicet 1500 XR Xr Tablet
About Epicet 1500 XR Xr Tablet
Epicet 1500 XR is a prescription tablet that helps control certain types of epileptic seizures. It belongs to a group of medicines used alongside other epilepsy treatments or on its own, depending on what the doctor advises.
There are 34 brands of Levetiracetam listed in Bangladesh. The lowest listed price is Citazar 250 mg Tablet at ৳ 15.11 per unit.
What is Epicet 1500 XR Xr Tablet?
Epicet 1500 XR contains levetiracetam, an anti-epileptic medicine. It works by attaching to a specific target in the brain, which is thought to help steady the unusual electrical activity that leads to seizures. Doctors use it either alone or together with other epilepsy medicines, depending on the person's situation. It comes as an extended-release tablet in a 1500 mg strength. Because epilepsy treatment is highly individual, the doctor decides whether this medicine is right and how it should be used. Always follow the prescription and do not change anything without medical advice.
Uses of Epicet 1500 XR
Epicet 1500 XR is used to treat partial-onset seizures, which are seizures that begin in one part of the brain and may or may not spread to the whole brain. Doctors may prescribe it as the only epilepsy medicine for some adults and adolescents with newly diagnosed epilepsy, or as an add-on treatment for other age groups. The exact role depends on the doctor's assessment. It is not a general remedy for all seizure types, and only a qualified doctor can decide if it suits a particular person.
How to use Epicet 1500 XR
Take Epicet 1500 XR exactly as your doctor tells you. The doctor decides the dose, how often to take it, and how long the course should last. Swallow the extended-release tablet whole with water, and do not crush or chew it unless your doctor or pharmacist says otherwise. Try to take it at the same times each day to help you remember. Do not stop suddenly, because stopping epilepsy medicine too quickly can be harmful. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Epicet 1500 XR
Some people may notice side effects while taking Epicet 1500 XR. In adults, the more common ones include sleepiness, weakness, infection and dizziness. Children may experience tiredness, aggression, a blocked nose, reduced appetite and irritability. Most side effects are not dangerous, but you should tell your doctor if they bother you or do not go away. Serious problems are rare, but seek medical help right away if you have unusual symptoms, severe drowsiness, or signs of an infection. Your doctor can advise on managing side effects.
Safety and precautions
Before taking Epicet 1500 XR, tell your doctor about any kidney or liver problems, because the dose may need to be adjusted. Also mention any history of low blood cell counts or serious allergic reactions, especially to levetiracetam or similar medicines. This medicine is not recommended during pregnancy or in women who could become pregnant and are not using contraception, unless the doctor considers it necessary. It passes into breast milk, so breastfeeding is not recommended unless the doctor decides the benefits outweigh the risks. Always ask your doctor or pharmacist before starting or stopping this medicine.
Frequently asked questions
What is Epicet 1500 XR used for and what kind of medicine is it?
Epicet 1500 XR is an anti-epileptic medicine containing levetiracetam. It is used to treat partial-onset seizures, either alone or together with other epilepsy medicines, depending on the doctor's assessment. It is not suitable for every type of seizure.
How should I take Epicet 1500 XR?
Your doctor will decide the dose, how often you take it, and how long you need it. Swallow the extended-release tablet whole with water and do not crush or chew it unless your doctor or pharmacist says otherwise. Never stop the medicine suddenly without medical advice.
How should I store Epicet 1500 XR?
Keep Epicet 1500 XR in a cool, dry place away from light, and do not store it above the temperature your pharmacist advises. Keep all medicines out of the reach of children. Do not use the tablets after the expiry date, and ask your pharmacist how to dispose of any unused medicine.
Who should ask a doctor before taking Epicet 1500 XR?
Anyone with kidney or liver problems, a history of low blood cell counts, or an allergy to levetiracetam should speak to a doctor first. Pregnant women, women who could become pregnant, and breastfeeding mothers should also ask their doctor before using this medicine.
Indications
- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy. ... Read more
- in the treatment of partial-onset seizures with or without secondary generalization in adults, adolescents, children and infants from 1 month of age with epilepsy.
- in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
- in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Dosage & Administration
Adults (≥18 years) and adolescents (12 to 17 years) weighing 50 kg or more: The initial therapeutic dose is 500 mg twice daily. This dose can be started on the first day of treatment. Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increases or decrease every two to four weeks.
Pediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Oral solution is the preferred formulation for use in this population. In addition, the available dose strengths of the tablets are not appropriate for initial treatment in children weighing less than 25 kg, for patients unable to swallow tablets or for the administration of doses below 250 mg. In all of the above cases, oral solution should be used.
- Monotherapy: The safety and efficacy of levetiracetam in children and adolescents below 16 years as monotherapy treatment have not been established.
- Add-on therapy: Oral solution is the preferred formulation for use in infants and children under the age of 6 years. For children 6 years and above, oral solution should be used for doses under 250 mg, for doses not in multiples of 250 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. The lowest effective dose should be used. The starting dose for a child or adolescent of 25 kg should be 250 mg twice daily with a maximum dose of 750 mg twice daily. Dosing for children 50 kg or greater is the same as in adults.
- Add-on therapy: For infants aged from 1 month to less than 6 months: The oral solution is the formulation to use in infants.
Interaction
Probenecid: Probenecid (500 mg four times daily), a renal tubular secretion blocking agent, has been shown to inhibit the renal clearance of the primary metabolite but not of levetiracetam. Nevertheless, the concentration of this metabolite remains low.
Methotrexate: Concomitant administration of levetiracetam and methotrexate has been reported to decrease methotrexate clearance, resulting in increased/prolonged blood methotrexate concentration to potentially toxic levels. Blood methotrexate and levetiracetam levels should be carefully monitored in patients treated concomitantly with the two drugs.
Laxatives: There have been isolated reports of decreased levetiracetam efficacy when the osmotic laxative macrogol has been concomitantly administered with oral levetiracetam. Therefore, macrogol should not be taken orally for one hour before and for one hour after taking levetiracetam.
Food and alcohol: The extent of absorption of levetiracetam was not altered by food, but the rate of absorption was slightly reduced. No data on the interaction of levetiracetam with alcohol are available.
Contraindications
Side Effects
- Adult patients: somnolence, asthenia, infection and dizziness
- Pediatric patients: fatigue, aggression, nasal congestion, decreased appetite, and irritability
Pregnancy & Lactation
Precautions & Warnings
Acute kidney injury: The use of levetiracetam has been very rarely associated with acute kidney injury with a time to onset ranging from a few days to several months.
Blood cell counts: Rare cases of decreased blood cell counts (neutropenia, agranulocytosis, leucopenia, thrombocytopenia and pancytopenia) have been described in association with levetiracetam administration, generally at the beginning of the treatment. Complete blood cell counts are advised in patients experiencing important weakness, pyrexia, recurrent infections or coagulation disorders.
Suicide: Suicide, suicide attempt, suicidal ideation and behaviour have been reported in patients treated with anti-epileptic agents (including levetiracetam). A meta-analysis of randomized placebo-controlled trials of anti-epileptic medicinal products has shown a small increased risk of suicidal thoughts and behaviour. The mechanism of this risk is not known. Therefore patients should be monitored for signs of depression and/or suicidal ideation and behaviours and appropriate treatment should be considered. Patients (and caregivers of patients) should be advised to seek medical advice should signs of depression and/or suicidal ideation or behaviour emerge.
Paediatric population: The tablet formulation is not adapted for use in infants and children under the age of 6 years. Available data in children did not suggest an impact on growth and puberty. However, long term effects on learning, intelligence, growth, endocrine function, puberty and childbearing potential in children remain unknown.
Overdose Effects
Storage Conditions
Alternative brands of Levetiracetam
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.